| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 65 | 2025 | 590 | 12.880 |
Why?
|
| Intestinal Mucosa | 112 | 2025 | 824 | 11.820 |
Why?
|
| Inflammatory Bowel Diseases | 33 | 2025 | 646 | 6.960 |
Why?
|
| Microbiota | 26 | 2024 | 425 | 5.330 |
Why?
|
| Diet | 21 | 2025 | 460 | 4.840 |
Why?
|
| Dysbiosis | 18 | 2025 | 91 | 4.640 |
Why?
|
| Heat-Shock Proteins | 27 | 2016 | 177 | 4.630 |
Why?
|
| Colon | 42 | 2025 | 540 | 4.410 |
Why?
|
| Gastrointestinal Tract | 16 | 2025 | 195 | 4.150 |
Why?
|
| Sodium-Hydrogen Exchangers | 39 | 2010 | 78 | 4.080 |
Why?
|
| Animals | 272 | 2025 | 28041 | 3.620 |
Why?
|
| Colitis | 17 | 2025 | 261 | 3.590 |
Why?
|
| Inflammation | 36 | 2025 | 1049 | 3.440 |
Why?
|
| Mice | 137 | 2025 | 12233 | 3.070 |
Why?
|
| Intestines | 30 | 2019 | 432 | 2.990 |
Why?
|
| Diet, High-Fat | 18 | 2022 | 135 | 2.780 |
Why?
|
| Obesity | 19 | 2022 | 1019 | 2.710 |
Why?
|
| Intestine, Small | 15 | 2018 | 310 | 2.680 |
Why?
|
| HSP70 Heat-Shock Proteins | 13 | 2025 | 117 | 2.520 |
Why?
|
| Lipid Metabolism | 11 | 2023 | 214 | 2.460 |
Why?
|
| Neoplasm Proteins | 15 | 2016 | 538 | 2.410 |
Why?
|
| Interleukin-10 | 13 | 2021 | 163 | 2.380 |
Why?
|
| Epithelial Cells | 32 | 2023 | 700 | 2.360 |
Why?
|
| Cystic Fibrosis | 8 | 2015 | 119 | 2.350 |
Why?
|
| Bacteria | 19 | 2025 | 509 | 2.280 |
Why?
|
| Feces | 23 | 2025 | 360 | 2.220 |
Why?
|
| Sodium | 32 | 2013 | 329 | 2.190 |
Why?
|
| Sirtuin 1 | 8 | 2021 | 36 | 2.140 |
Why?
|
| Fecal Microbiota Transplantation | 8 | 2025 | 80 | 2.080 |
Why?
|
| Circadian Clocks | 5 | 2023 | 66 | 2.030 |
Why?
|
| Liver | 15 | 2023 | 1207 | 1.960 |
Why?
|
| Mice, Inbred C57BL | 59 | 2025 | 3430 | 1.950 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 10 | 2015 | 57 | 1.950 |
Why?
|
| Colitis, Ulcerative | 18 | 2025 | 800 | 1.930 |
Why?
|
| Disease Models, Animal | 50 | 2025 | 2491 | 1.850 |
Why?
|
| Dietary Fats | 9 | 2016 | 135 | 1.850 |
Why?
|
| Sinusitis | 5 | 2017 | 213 | 1.830 |
Why?
|
| Humans | 223 | 2025 | 93615 | 1.820 |
Why?
|
| Glutamine | 9 | 2011 | 93 | 1.820 |
Why?
|
| Autophagy | 7 | 2019 | 172 | 1.760 |
Why?
|
| NF-kappa B | 12 | 2022 | 408 | 1.710 |
Why?
|
| Uric Acid | 2 | 2025 | 137 | 1.700 |
Why?
|
| Paranasal Sinuses | 4 | 2017 | 60 | 1.700 |
Why?
|
| Metagenome | 11 | 2024 | 116 | 1.630 |
Why?
|
| Rats | 73 | 2022 | 4042 | 1.630 |
Why?
|
| Vitamin D | 6 | 2022 | 272 | 1.590 |
Why?
|
| Bile Acids and Salts | 11 | 2025 | 77 | 1.560 |
Why?
|
| Tumor Necrosis Factor-alpha | 16 | 2022 | 688 | 1.560 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2022 | 70 | 1.540 |
Why?
|
| Plant Extracts | 9 | 2022 | 247 | 1.530 |
Why?
|
| Ileum | 28 | 2025 | 167 | 1.500 |
Why?
|
| RNA, Messenger | 39 | 2022 | 2020 | 1.450 |
Why?
|
| Adipose Tissue | 11 | 2022 | 270 | 1.420 |
Why?
|
| Butyrates | 8 | 2025 | 56 | 1.400 |
Why?
|
| Gastrointestinal Motility | 3 | 2025 | 26 | 1.380 |
Why?
|
| Signal Transduction | 29 | 2020 | 3498 | 1.370 |
Why?
|
| Hypertension | 7 | 2025 | 758 | 1.340 |
Why?
|
| Host-Pathogen Interactions | 8 | 2021 | 240 | 1.330 |
Why?
|
| Cells, Cultured | 40 | 2017 | 2828 | 1.330 |
Why?
|
| Adipocytes | 6 | 2021 | 169 | 1.320 |
Why?
|
| Colonic Neoplasms | 11 | 2020 | 579 | 1.320 |
Why?
|
| Male | 135 | 2025 | 44578 | 1.310 |
Why?
|
| Anti-Bacterial Agents | 18 | 2025 | 836 | 1.310 |
Why?
|
| Apoptosis | 20 | 2016 | 1719 | 1.290 |
Why?
|
| Circadian Rhythm | 4 | 2022 | 285 | 1.280 |
Why?
|
| Colonic Pouches | 8 | 2025 | 97 | 1.240 |
Why?
|
| Cell Line | 38 | 2019 | 2459 | 1.220 |
Why?
|
| Gene Expression Regulation | 18 | 2022 | 1980 | 1.210 |
Why?
|
| Proctocolectomy, Restorative | 8 | 2025 | 115 | 1.200 |
Why?
|
| HMGB1 Protein | 5 | 2019 | 18 | 1.170 |
Why?
|
| Fatty Acids, Volatile | 6 | 2025 | 35 | 1.170 |
Why?
|
| Cyclic AMP | 16 | 2013 | 276 | 1.160 |
Why?
|
| RNA, Ribosomal, 16S | 18 | 2025 | 259 | 1.140 |
Why?
|
| Precision Medicine | 3 | 2020 | 456 | 1.130 |
Why?
|
| Cytokines | 19 | 2025 | 863 | 1.090 |
Why?
|
| Neointima | 4 | 2020 | 14 | 1.090 |
Why?
|
| Fruit | 3 | 2025 | 81 | 1.090 |
Why?
|
| Fatty Liver | 4 | 2018 | 106 | 1.060 |
Why?
|
| Interferon-gamma | 7 | 2010 | 460 | 1.050 |
Why?
|
| Gastrointestinal Diseases | 3 | 2015 | 149 | 1.050 |
Why?
|
| Membrane Proteins | 13 | 2020 | 1260 | 1.050 |
Why?
|
| Irritable Bowel Syndrome | 3 | 2017 | 46 | 1.040 |
Why?
|
| Endothelial Cells | 7 | 2017 | 477 | 1.030 |
Why?
|
| Sumoylation | 5 | 2016 | 19 | 1.020 |
Why?
|
| Diabetes Mellitus, Experimental | 9 | 2018 | 201 | 1.020 |
Why?
|
| Immunohistochemistry | 12 | 2025 | 1790 | 1.020 |
Why?
|
| Heat-Shock Response | 6 | 2011 | 54 | 1.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 9 | 2012 | 32 | 1.010 |
Why?
|
| Probiotics | 7 | 2020 | 92 | 1.010 |
Why?
|
| Pouchitis | 6 | 2025 | 57 | 1.000 |
Why?
|
| Rats, Sprague-Dawley | 30 | 2022 | 1243 | 1.000 |
Why?
|
| Fatty Acids | 4 | 2019 | 145 | 0.980 |
Why?
|
| Intestinal Absorption | 16 | 2018 | 125 | 0.980 |
Why?
|
| Mice, Knockout | 29 | 2025 | 2121 | 0.970 |
Why?
|
| Vegetables | 2 | 2025 | 50 | 0.950 |
Why?
|
| Carotid Artery Injuries | 3 | 2020 | 21 | 0.930 |
Why?
|
| Gene Expression | 15 | 2015 | 1302 | 0.920 |
Why?
|
| Cardiovascular Diseases | 3 | 2025 | 755 | 0.920 |
Why?
|
| Caco-2 Cells | 23 | 2023 | 125 | 0.910 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2016 | 91 | 0.900 |
Why?
|
| Microvilli | 23 | 2010 | 44 | 0.900 |
Why?
|
| Gastrointestinal Transit | 1 | 2025 | 20 | 0.890 |
Why?
|
| Female | 74 | 2025 | 48779 | 0.890 |
Why?
|
| Nuts | 1 | 2025 | 4 | 0.890 |
Why?
|
| Oxidants | 10 | 2012 | 86 | 0.890 |
Why?
|
| Biodiversity | 5 | 2019 | 239 | 0.890 |
Why?
|
| Diarrhea | 15 | 2009 | 179 | 0.890 |
Why?
|
| Hyperuricemia | 1 | 2025 | 25 | 0.880 |
Why?
|
| Folic Acid | 1 | 2025 | 62 | 0.880 |
Why?
|
| Stress, Physiological | 6 | 2017 | 246 | 0.880 |
Why?
|
| Jejunum | 16 | 2016 | 76 | 0.880 |
Why?
|
| Adiponectin | 2 | 2015 | 21 | 0.870 |
Why?
|
| Lipopolysaccharides | 8 | 2025 | 300 | 0.850 |
Why?
|
| Rhinitis | 2 | 2017 | 183 | 0.850 |
Why?
|
| Bilophila | 2 | 2015 | 3 | 0.830 |
Why?
|
| Transcriptome | 9 | 2025 | 760 | 0.830 |
Why?
|
| Paneth Cells | 2 | 2023 | 10 | 0.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2016 | 1231 | 0.820 |
Why?
|
| Colorectal Neoplasms | 6 | 2023 | 1054 | 0.820 |
Why?
|
| Cell Proliferation | 11 | 2020 | 1735 | 0.810 |
Why?
|
| Macrophages | 9 | 2022 | 610 | 0.810 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 20 | 2010 | 33 | 0.800 |
Why?
|
| Peptide YY | 1 | 2023 | 9 | 0.800 |
Why?
|
| Bacteroides thetaiotaomicron | 1 | 2023 | 6 | 0.800 |
Why?
|
| Candida | 1 | 2023 | 20 | 0.790 |
Why?
|
| Blotting, Western | 22 | 2019 | 775 | 0.790 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2016 | 109 | 0.780 |
Why?
|
| 3T3-L1 Cells | 5 | 2015 | 35 | 0.780 |
Why?
|
| Peptide Fragments | 3 | 2023 | 469 | 0.770 |
Why?
|
| Pseudomonas Infections | 5 | 2017 | 94 | 0.760 |
Why?
|
| Wound Healing | 4 | 2021 | 373 | 0.760 |
Why?
|
| Muscle, Skeletal | 5 | 2021 | 474 | 0.750 |
Why?
|
| Antifungal Agents | 1 | 2023 | 122 | 0.750 |
Why?
|
| Cytoprotection | 6 | 2017 | 51 | 0.740 |
Why?
|
| Pregnancy Complications, Cardiovascular | 6 | 2025 | 107 | 0.730 |
Why?
|
| Panax | 8 | 2017 | 171 | 0.730 |
Why?
|
| Insulin Resistance | 5 | 2016 | 379 | 0.720 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2022 | 109 | 0.710 |
Why?
|
| Pseudomonas aeruginosa | 12 | 2017 | 199 | 0.700 |
Why?
|
| Amyloidosis | 5 | 2024 | 132 | 0.700 |
Why?
|
| Exercise | 4 | 2025 | 353 | 0.690 |
Why?
|
| Models, Animal | 7 | 2018 | 281 | 0.690 |
Why?
|
| Endocytosis | 5 | 2009 | 184 | 0.690 |
Why?
|
| Inflammation Mediators | 6 | 2025 | 159 | 0.670 |
Why?
|
| MAP Kinase Signaling System | 4 | 2015 | 200 | 0.670 |
Why?
|
| Insulin | 7 | 2016 | 1185 | 0.670 |
Why?
|
| MicroRNAs | 8 | 2020 | 580 | 0.650 |
Why?
|
| Exercise Therapy | 6 | 2025 | 94 | 0.650 |
Why?
|
| Molecular Typing | 1 | 2020 | 19 | 0.650 |
Why?
|
| Ruminococcus | 1 | 2020 | 2 | 0.640 |
Why?
|
| Chloramines | 13 | 2006 | 20 | 0.640 |
Why?
|
| Synaptotagmin I | 3 | 2009 | 16 | 0.640 |
Why?
|
| Protein Biosynthesis | 6 | 2010 | 373 | 0.630 |
Why?
|
| Metabolic Diseases | 2 | 2020 | 57 | 0.630 |
Why?
|
| Calcium | 15 | 2009 | 1175 | 0.630 |
Why?
|
| Sepsis | 10 | 2018 | 388 | 0.620 |
Why?
|
| Transcription, Genetic | 5 | 2016 | 1115 | 0.610 |
Why?
|
| HSP72 Heat-Shock Proteins | 13 | 2005 | 24 | 0.610 |
Why?
|
| Chlorides | 8 | 2008 | 100 | 0.610 |
Why?
|
| Constipation | 3 | 2017 | 66 | 0.610 |
Why?
|
| Carotid Arteries | 2 | 2020 | 131 | 0.600 |
Why?
|
| Communications Media | 1 | 2019 | 2 | 0.600 |
Why?
|
| Crohn Disease | 6 | 2025 | 808 | 0.600 |
Why?
|
| Molecular Chaperones | 11 | 2016 | 124 | 0.600 |
Why?
|
| Neoplasms | 8 | 2025 | 3171 | 0.590 |
Why?
|
| Proteolysis | 3 | 2016 | 123 | 0.590 |
Why?
|
| Antihypertensive Agents | 4 | 2025 | 262 | 0.590 |
Why?
|
| Serotonin | 5 | 2017 | 209 | 0.590 |
Why?
|
| Organic Cation Transport Proteins | 2 | 2010 | 13 | 0.590 |
Why?
|
| Acetylcysteine | 3 | 2012 | 73 | 0.580 |
Why?
|
| Phosphorylation | 15 | 2017 | 1130 | 0.580 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 5 | 2008 | 88 | 0.580 |
Why?
|
| Carrier Proteins | 11 | 2002 | 660 | 0.580 |
Why?
|
| Nasal Mucosa | 3 | 2017 | 193 | 0.580 |
Why?
|
| Dose-Response Relationship, Drug | 17 | 2017 | 1913 | 0.580 |
Why?
|
| Diabetic Angiopathies | 2 | 2016 | 37 | 0.560 |
Why?
|
| Choroidal Neovascularization | 3 | 2023 | 23 | 0.560 |
Why?
|
| Ezetimibe | 2 | 2015 | 37 | 0.560 |
Why?
|
| Chronic Disease | 12 | 2025 | 962 | 0.560 |
Why?
|
| Oxidative Stress | 9 | 2014 | 467 | 0.550 |
Why?
|
| Steroid Hydroxylases | 2 | 2017 | 13 | 0.550 |
Why?
|
| Genetic Vectors | 2 | 2013 | 422 | 0.550 |
Why?
|
| Tight Junctions | 7 | 2017 | 153 | 0.550 |
Why?
|
| Intestinal Diseases | 2 | 2017 | 84 | 0.550 |
Why?
|
| Biological Transport | 20 | 2013 | 399 | 0.550 |
Why?
|
| Biomarkers | 10 | 2025 | 1912 | 0.550 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2017 | 4 | 0.540 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 123 | 0.530 |
Why?
|
| Micronutrients | 1 | 2017 | 18 | 0.530 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2017 | 41 | 0.530 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2017 | 4 | 0.530 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2015 | 353 | 0.530 |
Why?
|
| Antioxidants | 2 | 2017 | 231 | 0.530 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2017 | 44 | 0.520 |
Why?
|
| Hepatocytes | 2 | 2015 | 129 | 0.520 |
Why?
|
| Azoxymethane | 2 | 2017 | 84 | 0.520 |
Why?
|
| Premature Birth | 2 | 2025 | 130 | 0.520 |
Why?
|
| Adult | 32 | 2025 | 27955 | 0.520 |
Why?
|
| Transfection | 15 | 2012 | 878 | 0.520 |
Why?
|
| Endothelial Progenitor Cells | 4 | 2019 | 12 | 0.520 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2017 | 11 | 0.520 |
Why?
|
| Dietary Fiber | 5 | 2021 | 46 | 0.520 |
Why?
|
| Energy Intake | 2 | 2017 | 97 | 0.510 |
Why?
|
| Dextran Sulfate | 7 | 2017 | 70 | 0.510 |
Why?
|
| Atherosclerosis | 5 | 2025 | 256 | 0.510 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2017 | 49 | 0.510 |
Why?
|
| Risk Factors | 10 | 2025 | 5912 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2016 | 1339 | 0.510 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2005 | 249 | 0.500 |
Why?
|
| Immunity, Mucosal | 5 | 2019 | 71 | 0.500 |
Why?
|
| Wnt-5a Protein | 1 | 2016 | 10 | 0.490 |
Why?
|
| Autoimmunity | 2 | 2016 | 189 | 0.490 |
Why?
|
| Adiposity | 6 | 2016 | 76 | 0.490 |
Why?
|
| Symporters | 3 | 2006 | 112 | 0.490 |
Why?
|
| Quinolones | 2 | 2014 | 57 | 0.480 |
Why?
|
| Immune Tolerance | 3 | 2021 | 376 | 0.480 |
Why?
|
| Cell Survival | 12 | 2020 | 1003 | 0.480 |
Why?
|
| Adenosine | 4 | 2024 | 274 | 0.470 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2016 | 42 | 0.470 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2016 | 4 | 0.470 |
Why?
|
| Lipolysis | 1 | 2015 | 24 | 0.470 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 107 | 0.470 |
Why?
|
| Metagenomics | 6 | 2024 | 100 | 0.470 |
Why?
|
| Protein Kinases | 2 | 2016 | 210 | 0.450 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 92 | 0.450 |
Why?
|
| Glucose | 12 | 2023 | 692 | 0.450 |
Why?
|
| Enterotoxins | 3 | 2004 | 22 | 0.450 |
Why?
|
| Hydrogen-Ion Concentration | 17 | 2014 | 490 | 0.450 |
Why?
|
| Down-Regulation | 11 | 2019 | 523 | 0.450 |
Why?
|
| Middle Aged | 27 | 2025 | 27621 | 0.450 |
Why?
|
| Vitamins | 4 | 2022 | 85 | 0.450 |
Why?
|
| Republic of Korea | 2 | 2025 | 37 | 0.450 |
Why?
|
| Transcription Factors | 7 | 2025 | 1690 | 0.440 |
Why?
|
| Energy Metabolism | 6 | 2021 | 299 | 0.440 |
Why?
|
| Mitochondria, Muscle | 3 | 2021 | 25 | 0.440 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2012 | 392 | 0.440 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 13 | 0.440 |
Why?
|
| Macular Degeneration | 3 | 2025 | 50 | 0.440 |
Why?
|
| Alprostadil | 4 | 2013 | 25 | 0.440 |
Why?
|
| Aminophenols | 1 | 2014 | 4 | 0.440 |
Why?
|
| Time Factors | 20 | 2024 | 5406 | 0.440 |
Why?
|
| DNA, Bacterial | 7 | 2020 | 232 | 0.440 |
Why?
|
| Azetidines | 1 | 2015 | 36 | 0.430 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2015 | 59 | 0.430 |
Why?
|
| Dental Enamel | 2 | 2012 | 16 | 0.430 |
Why?
|
| Bacteroides | 4 | 2024 | 35 | 0.430 |
Why?
|
| Young Adult | 12 | 2025 | 6938 | 0.430 |
Why?
|
| Molecular Sequence Data | 15 | 2015 | 2889 | 0.430 |
Why?
|
| Alzheimer Disease | 4 | 2024 | 603 | 0.430 |
Why?
|
| Cell Movement | 5 | 2020 | 804 | 0.420 |
Why?
|
| Electrolytes | 9 | 1996 | 52 | 0.420 |
Why?
|
| Nutrition Surveys | 2 | 2025 | 125 | 0.420 |
Why?
|
| Aldosterone | 2 | 2008 | 55 | 0.420 |
Why?
|
| Clostridium Infections | 1 | 2016 | 128 | 0.410 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2025 | 35 | 0.410 |
Why?
|
| Hot Temperature | 4 | 2021 | 217 | 0.410 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 188 | 0.410 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2013 | 27 | 0.400 |
Why?
|
| Anticholesteremic Agents | 1 | 2015 | 154 | 0.400 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2018 | 36 | 0.400 |
Why?
|
| Enzyme Inhibitors | 7 | 2011 | 639 | 0.400 |
Why?
|
| Respiratory Mucosa | 2 | 2014 | 90 | 0.400 |
Why?
|
| Mentors | 1 | 2014 | 95 | 0.400 |
Why?
|
| Antiporters | 3 | 2012 | 15 | 0.400 |
Why?
|
| Germ-Free Life | 7 | 2021 | 83 | 0.400 |
Why?
|
| Quality of Life | 6 | 2025 | 1783 | 0.390 |
Why?
|
| Actins | 7 | 2006 | 467 | 0.390 |
Why?
|
| Bacterial Infections | 2 | 2018 | 179 | 0.390 |
Why?
|
| Diet, Western | 4 | 2023 | 45 | 0.390 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 5 | 2015 | 21 | 0.390 |
Why?
|
| Sus scrofa | 3 | 2013 | 49 | 0.380 |
Why?
|
| Quorum Sensing | 3 | 2007 | 28 | 0.380 |
Why?
|
| Respiratory System | 1 | 2013 | 117 | 0.380 |
Why?
|
| Pregnancy | 14 | 2025 | 3148 | 0.380 |
Why?
|
| Amiloride | 16 | 2008 | 36 | 0.380 |
Why?
|
| Biota | 1 | 2013 | 21 | 0.380 |
Why?
|
| Ion Transport | 7 | 2016 | 82 | 0.380 |
Why?
|
| Gene Expression Profiling | 7 | 2025 | 1516 | 0.380 |
Why?
|
| Up-Regulation | 7 | 2012 | 729 | 0.380 |
Why?
|
| Taurocholic Acid | 1 | 2012 | 6 | 0.370 |
Why?
|
| Wet Macular Degeneration | 2 | 2023 | 22 | 0.370 |
Why?
|
| Lung | 5 | 2022 | 1365 | 0.370 |
Why?
|
| Gastroenterology | 2 | 2014 | 157 | 0.370 |
Why?
|
| Bacillus subtilis | 3 | 2018 | 89 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2017 | 2465 | 0.370 |
Why?
|
| Faculty, Medical | 1 | 2014 | 187 | 0.370 |
Why?
|
| Adaptation, Physiological | 3 | 2006 | 329 | 0.370 |
Why?
|
| Regeneration | 2 | 2025 | 159 | 0.360 |
Why?
|
| Cecum | 8 | 2020 | 78 | 0.360 |
Why?
|
| 3' Untranslated Regions | 2 | 2010 | 98 | 0.360 |
Why?
|
| Culture Media, Conditioned | 3 | 2009 | 103 | 0.360 |
Why?
|
| Salmonella Infections | 3 | 2019 | 18 | 0.360 |
Why?
|
| Contractile Proteins | 1 | 2012 | 52 | 0.360 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2025 | 84 | 0.360 |
Why?
|
| Homeostasis | 5 | 2017 | 460 | 0.360 |
Why?
|
| Intestine, Large | 2 | 2010 | 15 | 0.360 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 1233 | 0.350 |
Why?
|
| Adenoviridae | 1 | 2013 | 340 | 0.350 |
Why?
|
| Bacterial Physiological Phenomena | 2 | 2018 | 42 | 0.350 |
Why?
|
| Autophagy-Related Protein 5 | 3 | 2016 | 11 | 0.350 |
Why?
|
| Phenotype | 9 | 2025 | 2543 | 0.350 |
Why?
|
| Adenoma | 2 | 2012 | 258 | 0.350 |
Why?
|
| Morus | 2 | 2022 | 2 | 0.340 |
Why?
|
| Mice, Transgenic | 9 | 2024 | 1584 | 0.340 |
Why?
|
| Chickens | 14 | 2004 | 193 | 0.340 |
Why?
|
| Mesalamine | 2 | 2005 | 88 | 0.340 |
Why?
|
| Takotsubo Cardiomyopathy | 2 | 2022 | 13 | 0.340 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2006 | 38 | 0.340 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2015 | 885 | 0.340 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 1866 | 0.330 |
Why?
|
| Lymphedema | 2 | 2023 | 84 | 0.330 |
Why?
|
| Polyamines | 1 | 2011 | 37 | 0.330 |
Why?
|
| Protein Binding | 9 | 2017 | 1528 | 0.330 |
Why?
|
| Endothelium, Vascular | 5 | 2016 | 436 | 0.330 |
Why?
|
| Microdissection | 1 | 2010 | 18 | 0.330 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 76 | 0.330 |
Why?
|
| Salmonella typhimurium | 2 | 2008 | 32 | 0.320 |
Why?
|
| Phosphoproteins | 4 | 2005 | 259 | 0.320 |
Why?
|
| Milk | 3 | 2017 | 56 | 0.320 |
Why?
|
| Receptors, Androgen | 3 | 2016 | 119 | 0.320 |
Why?
|
| Dexamethasone | 3 | 2015 | 311 | 0.320 |
Why?
|
| Tryptases | 1 | 2010 | 11 | 0.320 |
Why?
|
| RNA, Small Interfering | 7 | 2010 | 555 | 0.320 |
Why?
|
| Acute Lung Injury | 2 | 2022 | 68 | 0.320 |
Why?
|
| Tumor Cells, Cultured | 6 | 2011 | 1025 | 0.320 |
Why?
|
| Genome, Human | 1 | 2015 | 823 | 0.320 |
Why?
|
| Interleukin-8 | 4 | 2013 | 88 | 0.310 |
Why?
|
| Infant, Newborn | 12 | 2025 | 2482 | 0.310 |
Why?
|
| Phylogeny | 7 | 2024 | 1265 | 0.310 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 767 | 0.310 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 6 | 2014 | 122 | 0.310 |
Why?
|
| Immunity, Innate | 5 | 2017 | 463 | 0.310 |
Why?
|
| Protein Kinase C | 4 | 2011 | 261 | 0.310 |
Why?
|
| Angiotensin II | 2 | 2012 | 94 | 0.310 |
Why?
|
| Lactobacillus plantarum | 1 | 2009 | 4 | 0.310 |
Why?
|
| Cytoplasmic Granules | 1 | 2010 | 94 | 0.300 |
Why?
|
| Ginsenosides | 4 | 2016 | 124 | 0.300 |
Why?
|
| Cell Division | 5 | 2007 | 690 | 0.300 |
Why?
|
| Proteasome Inhibitors | 1 | 2009 | 52 | 0.300 |
Why?
|
| Dietary Supplements | 2 | 2022 | 131 | 0.300 |
Why?
|
| Symbiosis | 3 | 2023 | 128 | 0.300 |
Why?
|
| Vitamin E | 2 | 2007 | 34 | 0.300 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 3 | 2015 | 8 | 0.300 |
Why?
|
| Genomics | 1 | 2015 | 848 | 0.300 |
Why?
|
| Digestion | 2 | 2019 | 8 | 0.300 |
Why?
|
| Prebiotics | 2 | 2020 | 8 | 0.290 |
Why?
|
| Sequence Analysis, DNA | 4 | 2020 | 891 | 0.290 |
Why?
|
| Aminosalicylic Acids | 2 | 2005 | 41 | 0.290 |
Why?
|
| Biological Evolution | 1 | 2017 | 1019 | 0.290 |
Why?
|
| Actin Cytoskeleton | 1 | 2010 | 196 | 0.290 |
Why?
|
| Zanthoxylum | 3 | 2017 | 9 | 0.290 |
Why?
|
| Zingiberaceae | 3 | 2017 | 10 | 0.290 |
Why?
|
| Adipogenesis | 3 | 2021 | 41 | 0.290 |
Why?
|
| Mutation | 5 | 2015 | 4266 | 0.280 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 657 | 0.280 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2020 | 163 | 0.280 |
Why?
|
| Viruses | 2 | 2022 | 64 | 0.280 |
Why?
|
| Body Weight | 4 | 2021 | 449 | 0.280 |
Why?
|
| Bacteroides fragilis | 3 | 2024 | 46 | 0.280 |
Why?
|
| Tissue Culture Techniques | 4 | 2013 | 81 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2018 | 665 | 0.280 |
Why?
|
| Pregnancy Outcome | 3 | 2024 | 270 | 0.280 |
Why?
|
| Bacteriological Techniques | 2 | 2020 | 38 | 0.270 |
Why?
|
| Organelle Biogenesis | 2 | 2019 | 7 | 0.270 |
Why?
|
| Parathyroid Hormone | 1 | 2009 | 227 | 0.270 |
Why?
|
| Bacterial Proteins | 6 | 2018 | 878 | 0.270 |
Why?
|
| Swine | 6 | 2013 | 587 | 0.270 |
Why?
|
| Flagellin | 1 | 2008 | 18 | 0.270 |
Why?
|
| Genetic Therapy | 2 | 2013 | 366 | 0.270 |
Why?
|
| Aged | 13 | 2025 | 20469 | 0.270 |
Why?
|
| Hyperplasia | 4 | 2020 | 147 | 0.270 |
Why?
|
| Escherichia coli | 4 | 2018 | 562 | 0.270 |
Why?
|
| Adenocarcinoma | 2 | 2007 | 1173 | 0.260 |
Why?
|
| Permeability | 8 | 2018 | 143 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2012 | 183 | 0.260 |
Why?
|
| Kinetics | 14 | 2007 | 1470 | 0.260 |
Why?
|
| Anions | 5 | 2013 | 30 | 0.260 |
Why?
|
| Rats, Inbred OLETF | 2 | 2018 | 3 | 0.260 |
Why?
|
| Cell Differentiation | 6 | 2015 | 1610 | 0.260 |
Why?
|
| Immediate-Early Proteins | 1 | 2008 | 161 | 0.260 |
Why?
|
| Adaptor Protein Complex mu Subunits | 1 | 2007 | 3 | 0.260 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2007 | 6 | 0.260 |
Why?
|
| Clathrin Heavy Chains | 1 | 2007 | 4 | 0.260 |
Why?
|
| Interleukin-6 | 4 | 2022 | 276 | 0.260 |
Why?
|
| Mice, Mutant Strains | 5 | 2017 | 219 | 0.260 |
Why?
|
| Models, Biological | 10 | 2018 | 1768 | 0.260 |
Why?
|
| Genetic Markers | 2 | 2020 | 469 | 0.250 |
Why?
|
| Cell Line, Transformed | 3 | 2010 | 152 | 0.250 |
Why?
|
| Epithelium | 12 | 2005 | 315 | 0.250 |
Why?
|
| Duodenum | 3 | 2025 | 110 | 0.250 |
Why?
|
| Thrombosis | 2 | 2022 | 309 | 0.250 |
Why?
|
| Enzyme Activation | 10 | 2015 | 672 | 0.250 |
Why?
|
| Diabetes Complications | 1 | 2008 | 170 | 0.250 |
Why?
|
| T-Lymphocytes | 6 | 2017 | 1275 | 0.250 |
Why?
|
| Barrett Esophagus | 1 | 2007 | 94 | 0.250 |
Why?
|
| Plasmids | 2 | 2024 | 272 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2014 | 364 | 0.240 |
Why?
|
| Bacterial Toxins | 3 | 2009 | 112 | 0.240 |
Why?
|
| Phenols | 2 | 2017 | 41 | 0.240 |
Why?
|
| Adhesins, Bacterial | 5 | 2005 | 36 | 0.240 |
Why?
|
| RNA Interference | 4 | 2015 | 379 | 0.240 |
Why?
|
| Lectins | 5 | 2005 | 82 | 0.240 |
Why?
|
| Calcium Signaling | 1 | 2007 | 139 | 0.240 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2007 | 160 | 0.240 |
Why?
|
| Serpins | 2 | 2017 | 31 | 0.240 |
Why?
|
| Myocytes, Cardiac | 3 | 2022 | 313 | 0.240 |
Why?
|
| Zonula Occludens-1 Protein | 4 | 2017 | 70 | 0.230 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 205 | 0.230 |
Why?
|
| Vitis | 2 | 2016 | 19 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2023 | 939 | 0.230 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 2756 | 0.230 |
Why?
|
| Animals, Newborn | 8 | 2017 | 519 | 0.230 |
Why?
|
| Antineoplastic Agents | 5 | 2012 | 2302 | 0.230 |
Why?
|
| Prognosis | 5 | 2025 | 3913 | 0.230 |
Why?
|
| Esophagus | 3 | 2019 | 113 | 0.230 |
Why?
|
| Chromatography, Liquid | 3 | 2016 | 102 | 0.230 |
Why?
|
| DNA Methylation | 1 | 2010 | 697 | 0.230 |
Why?
|
| Disease Progression | 4 | 2016 | 1531 | 0.230 |
Why?
|
| Rabbits | 14 | 2005 | 613 | 0.230 |
Why?
|
| Bariatric Surgery | 2 | 2019 | 208 | 0.230 |
Why?
|
| Cell Membrane | 9 | 2008 | 661 | 0.230 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2025 | 69 | 0.230 |
Why?
|
| Protective Factors | 1 | 2025 | 28 | 0.220 |
Why?
|
| Hyperoxaluria | 2 | 2023 | 26 | 0.220 |
Why?
|
| Pre-Eclampsia | 2 | 2025 | 261 | 0.220 |
Why?
|
| Vaccinia virus | 1 | 2005 | 20 | 0.220 |
Why?
|
| Beclin-1 | 2 | 2015 | 15 | 0.220 |
Why?
|
| Sulfasalazine | 1 | 2005 | 33 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 7 | 2015 | 890 | 0.220 |
Why?
|
| Anti-Ulcer Agents | 1 | 2005 | 22 | 0.220 |
Why?
|
| Phorbol 12,13-Dibutyrate | 6 | 1999 | 20 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 140 | 0.220 |
Why?
|
| Complement System Proteins | 1 | 2025 | 86 | 0.220 |
Why?
|
| Genes, Reporter | 5 | 2009 | 275 | 0.220 |
Why?
|
| Gastroenteritis | 2 | 2016 | 26 | 0.220 |
Why?
|
| Blotting, Northern | 8 | 2003 | 239 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 2 | 2024 | 281 | 0.220 |
Why?
|
| Aging | 3 | 2016 | 727 | 0.220 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2004 | 4 | 0.220 |
Why?
|
| Nitroprusside | 2 | 1996 | 25 | 0.220 |
Why?
|
| Hypotension | 1 | 2025 | 72 | 0.220 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 170 | 0.220 |
Why?
|
| Cholesterol | 3 | 2020 | 364 | 0.220 |
Why?
|
| Prodrugs | 1 | 2005 | 51 | 0.220 |
Why?
|
| RNA, Bacterial | 2 | 2017 | 101 | 0.210 |
Why?
|
| Kidney Cortex | 2 | 1994 | 30 | 0.210 |
Why?
|
| Placenta Growth Factor | 1 | 2025 | 81 | 0.210 |
Why?
|
| Microglia | 2 | 2024 | 123 | 0.210 |
Why?
|
| Esophageal Neoplasms | 1 | 2007 | 344 | 0.210 |
Why?
|
| Calpain | 2 | 2015 | 113 | 0.210 |
Why?
|
| Labetalol | 1 | 2024 | 6 | 0.210 |
Why?
|
| Nifedipine | 1 | 2024 | 24 | 0.210 |
Why?
|
| Hyperthermia, Induced | 1 | 2005 | 75 | 0.210 |
Why?
|
| Bifidobacterium | 3 | 2024 | 18 | 0.210 |
Why?
|
| Behavior Therapy | 1 | 2025 | 93 | 0.210 |
Why?
|
| Stem Cells | 3 | 2025 | 386 | 0.210 |
Why?
|
| Superantigens | 1 | 2004 | 24 | 0.210 |
Why?
|
| Chemokine CCL2 | 4 | 2013 | 45 | 0.210 |
Why?
|
| Fetus | 1 | 2025 | 235 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2025 | 105 | 0.210 |
Why?
|
| Tetracycline | 1 | 2024 | 13 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2015 | 201 | 0.210 |
Why?
|
| Treatment Outcome | 10 | 2024 | 9108 | 0.210 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2004 | 34 | 0.210 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2017 | 215 | 0.210 |
Why?
|
| Interleukin-2 | 2 | 2003 | 244 | 0.200 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 185 | 0.200 |
Why?
|
| Dinoprostone | 5 | 1996 | 71 | 0.200 |
Why?
|
| Delivery, Obstetric | 1 | 2024 | 121 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2015 | 454 | 0.200 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 49 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 245 | 0.200 |
Why?
|
| Shock, Septic | 2 | 2003 | 124 | 0.200 |
Why?
|
| Cancer Survivors | 1 | 2025 | 89 | 0.200 |
Why?
|
| Cell Membrane Permeability | 5 | 2005 | 121 | 0.200 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 260 | 0.200 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2015 | 146 | 0.200 |
Why?
|
| Counseling | 1 | 2025 | 168 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2019 | 123 | 0.200 |
Why?
|
| Postpartum Period | 1 | 2024 | 159 | 0.200 |
Why?
|
| Bile | 2 | 2023 | 60 | 0.200 |
Why?
|
| Interleukin-11 | 1 | 2003 | 20 | 0.200 |
Why?
|
| Biological Assay | 1 | 2023 | 82 | 0.200 |
Why?
|
| Retina | 2 | 2023 | 214 | 0.200 |
Why?
|
| Bacteroidetes | 3 | 2024 | 39 | 0.200 |
Why?
|
| Enterobacteriaceae | 1 | 2003 | 22 | 0.200 |
Why?
|
| Colorectal Surgery | 1 | 2023 | 22 | 0.190 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 1918 | 0.190 |
Why?
|
| Clonidine | 5 | 2009 | 33 | 0.190 |
Why?
|
| Fibroblasts | 8 | 2007 | 752 | 0.190 |
Why?
|
| Acclimatization | 1 | 2023 | 88 | 0.190 |
Why?
|
| Safflower Oil | 2 | 2013 | 7 | 0.190 |
Why?
|
| Endotoxins | 3 | 2005 | 36 | 0.190 |
Why?
|
| Gastrointestinal Agents | 1 | 2005 | 181 | 0.190 |
Why?
|
| Protein Transport | 4 | 2009 | 438 | 0.190 |
Why?
|
| Cluster Analysis | 4 | 2014 | 392 | 0.190 |
Why?
|
| Acidosis | 2 | 2002 | 53 | 0.190 |
Why?
|
| Th1 Cells | 2 | 2015 | 167 | 0.190 |
Why?
|
| In Situ Hybridization | 7 | 2011 | 303 | 0.190 |
Why?
|
| Loperamide | 2 | 2017 | 7 | 0.190 |
Why?
|
| Blood Glucose | 3 | 2016 | 868 | 0.190 |
Why?
|
| Cyclic GMP | 4 | 1998 | 62 | 0.190 |
Why?
|
| Diet, Fat-Restricted | 2 | 2013 | 30 | 0.190 |
Why?
|
| Colectomy | 2 | 2025 | 192 | 0.190 |
Why?
|
| Mice, Obese | 1 | 2022 | 49 | 0.190 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2015 | 18 | 0.190 |
Why?
|
| Bleomycin | 1 | 2022 | 99 | 0.190 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2017 | 337 | 0.190 |
Why?
|
| Oxidation-Reduction | 4 | 2016 | 410 | 0.190 |
Why?
|
| Reference Values | 5 | 2025 | 608 | 0.190 |
Why?
|
| Renal Insufficiency | 1 | 2023 | 98 | 0.190 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 26 | 0.180 |
Why?
|
| Risk Assessment | 2 | 2025 | 2444 | 0.180 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2023 | 66 | 0.180 |
Why?
|
| Virulence | 7 | 2015 | 273 | 0.180 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2015 | 56 | 0.180 |
Why?
|
| Inflammasomes | 1 | 2022 | 31 | 0.180 |
Why?
|
| Adaptive Immunity | 2 | 2015 | 179 | 0.180 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 1992 | 2 | 0.180 |
Why?
|
| Cell Culture Techniques | 2 | 2015 | 196 | 0.180 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 4 | 2015 | 70 | 0.180 |
Why?
|
| Neutrophil Activation | 1 | 2022 | 11 | 0.180 |
Why?
|
| Transplantation, Homologous | 1 | 2024 | 1014 | 0.180 |
Why?
|
| Chrysanthemum | 1 | 2021 | 1 | 0.180 |
Why?
|
| Gastric Mucosa | 2 | 2003 | 70 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2008 | 216 | 0.180 |
Why?
|
| Peptide Transporter 1 | 3 | 2006 | 3 | 0.180 |
Why?
|
| Postoperative Complications | 6 | 2025 | 2564 | 0.180 |
Why?
|
| Amino Acid Sequence | 8 | 2009 | 1993 | 0.180 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2019 | 17 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 9 | 2023 | 1102 | 0.180 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 208 | 0.180 |
Why?
|
| Mammaplasty | 1 | 2023 | 122 | 0.180 |
Why?
|
| Parenteral Nutrition | 2 | 2020 | 64 | 0.180 |
Why?
|
| Exocytosis | 3 | 2009 | 108 | 0.180 |
Why?
|
| Endotoxemia | 1 | 2001 | 18 | 0.180 |
Why?
|
| Ischemia | 2 | 2017 | 253 | 0.180 |
Why?
|
| Oxalobacter formigenes | 2 | 2023 | 5 | 0.170 |
Why?
|
| Electric Impedance | 5 | 2006 | 115 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2025 | 1262 | 0.170 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 1661 | 0.170 |
Why?
|
| Flowers | 1 | 2021 | 41 | 0.170 |
Why?
|
| Acetaminophen | 2 | 2023 | 61 | 0.170 |
Why?
|
| Retinal Diseases | 1 | 2022 | 84 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 537 | 0.170 |
Why?
|
| Anastomosis, Surgical | 4 | 2023 | 280 | 0.170 |
Why?
|
| Diet, Vegetarian | 1 | 2021 | 8 | 0.170 |
Why?
|
| Dietary Sugars | 1 | 2021 | 8 | 0.170 |
Why?
|
| Bone Marrow | 1 | 2023 | 409 | 0.170 |
Why?
|
| Cardiomegaly | 1 | 2022 | 111 | 0.170 |
Why?
|
| Oxalates | 2 | 2023 | 49 | 0.170 |
Why?
|
| Adipose Tissue, White | 2 | 2021 | 28 | 0.170 |
Why?
|
| Rats, Wistar | 6 | 2014 | 300 | 0.170 |
Why?
|
| beta Catenin | 3 | 2016 | 265 | 0.170 |
Why?
|
| Occludin | 4 | 2010 | 66 | 0.170 |
Why?
|
| Cytosol | 4 | 2015 | 192 | 0.170 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 2004 | 76 | 0.170 |
Why?
|
| Human Development | 1 | 2020 | 7 | 0.170 |
Why?
|
| Breast Cancer Lymphedema | 1 | 2020 | 5 | 0.170 |
Why?
|
| Environmental Health | 1 | 2020 | 10 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2018 | 1415 | 0.170 |
Why?
|
| Genome, Bacterial | 2 | 2024 | 142 | 0.160 |
Why?
|
| Digestive System Diseases | 1 | 2020 | 19 | 0.160 |
Why?
|
| Metadata | 1 | 2020 | 3 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 255 | 0.160 |
Why?
|
| Cefoperazone | 1 | 2020 | 1 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 367 | 0.160 |
Why?
|
| Health | 1 | 2020 | 27 | 0.160 |
Why?
|
| Immune System Diseases | 1 | 2020 | 25 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2011 | 457 | 0.160 |
Why?
|
| Immunoconjugates | 1 | 2021 | 129 | 0.160 |
Why?
|
| In Vitro Techniques | 11 | 2014 | 947 | 0.160 |
Why?
|
| Butyric Acid | 1 | 2020 | 12 | 0.160 |
Why?
|
| Biological Clocks | 1 | 2021 | 76 | 0.160 |
Why?
|
| Exosomes | 2 | 2019 | 60 | 0.160 |
Why?
|
| Cholic Acid | 1 | 2020 | 8 | 0.160 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 162 | 0.160 |
Why?
|
| Mass Screening | 1 | 2005 | 711 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2025 | 555 | 0.160 |
Why?
|
| Neutrophils | 1 | 2022 | 324 | 0.160 |
Why?
|
| Chloride-Bicarbonate Antiporters | 2 | 2011 | 10 | 0.160 |
Why?
|
| CD47 Antigen | 1 | 2020 | 24 | 0.160 |
Why?
|
| Kidney | 6 | 2006 | 1110 | 0.160 |
Why?
|
| Kidney Calculi | 1 | 2023 | 343 | 0.160 |
Why?
|
| Cell Adhesion | 3 | 2017 | 416 | 0.160 |
Why?
|
| Femoral Artery | 1 | 2020 | 90 | 0.150 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 37 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2020 | 109 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 82 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 61 | 0.150 |
Why?
|
| RNA | 3 | 2022 | 572 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 3158 | 0.150 |
Why?
|
| Adoptive Transfer | 2 | 2017 | 173 | 0.150 |
Why?
|
| Critical Illness | 6 | 2017 | 343 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 322 | 0.150 |
Why?
|
| Metabolome | 1 | 2020 | 62 | 0.150 |
Why?
|
| Medical Oncology | 2 | 2024 | 404 | 0.150 |
Why?
|
| PPAR gamma | 2 | 2017 | 75 | 0.150 |
Why?
|
| Immunoblotting | 7 | 2006 | 273 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2021 | 198 | 0.150 |
Why?
|
| Kinesiology, Applied | 1 | 2019 | 1 | 0.150 |
Why?
|
| Mouth | 1 | 2019 | 45 | 0.150 |
Why?
|
| Retrospective Studies | 10 | 2025 | 10186 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2019 | 53 | 0.150 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 173 | 0.150 |
Why?
|
| Receptors, Adrenergic, alpha | 3 | 1985 | 15 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 3 | 2015 | 1389 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 256 | 0.150 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 90 | 0.150 |
Why?
|
| Genetic Heterogeneity | 1 | 2019 | 69 | 0.150 |
Why?
|
| Fagopyrum | 1 | 2019 | 1 | 0.150 |
Why?
|
| Nitric Oxide | 2 | 2019 | 281 | 0.150 |
Why?
|
| Solute Carrier Family 22 Member 5 | 2 | 2010 | 5 | 0.150 |
Why?
|
| Malnutrition | 1 | 2019 | 36 | 0.150 |
Why?
|
| Mass Media | 1 | 2019 | 26 | 0.150 |
Why?
|
| Child | 4 | 2024 | 7359 | 0.150 |
Why?
|
| Colonic Diseases | 1 | 2019 | 59 | 0.150 |
Why?
|
| Bacterial Adhesion | 4 | 2009 | 83 | 0.150 |
Why?
|
| Exercise Test | 1 | 2020 | 152 | 0.150 |
Why?
|
| Polyethylene Glycols | 3 | 2021 | 373 | 0.150 |
Why?
|
| Lymph Node Excision | 1 | 2020 | 233 | 0.150 |
Why?
|
| Arteritis | 1 | 2018 | 9 | 0.150 |
Why?
|
| Carcinogenesis | 2 | 2019 | 235 | 0.140 |
Why?
|
| Public Opinion | 1 | 2019 | 50 | 0.140 |
Why?
|
| Food | 1 | 2019 | 92 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 408 | 0.140 |
Why?
|
| Vasculitis | 2 | 2016 | 40 | 0.140 |
Why?
|
| Adenylate Kinase | 1 | 2018 | 14 | 0.140 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 63 | 0.140 |
Why?
|
| Selenium | 2 | 2017 | 46 | 0.140 |
Why?
|
| Recombinant Proteins | 8 | 2006 | 982 | 0.140 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2018 | 13 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 87 | 0.140 |
Why?
|
| DNA Primers | 3 | 2015 | 528 | 0.140 |
Why?
|
| Organ Specificity | 3 | 2018 | 278 | 0.140 |
Why?
|
| Heat Shock Transcription Factors | 2 | 2011 | 10 | 0.140 |
Why?
|
| Random Allocation | 2 | 2012 | 307 | 0.140 |
Why?
|
| Rats, Long-Evans | 1 | 2018 | 49 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2024 | 83 | 0.140 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 153 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 299 | 0.140 |
Why?
|
| Organoids | 2 | 2019 | 76 | 0.140 |
Why?
|
| Vasodilation | 2 | 2017 | 91 | 0.140 |
Why?
|
| Homeodomain Proteins | 3 | 2010 | 556 | 0.140 |
Why?
|
| NAD | 2 | 2015 | 96 | 0.140 |
Why?
|
| Sex Factors | 2 | 2021 | 1104 | 0.140 |
Why?
|
| Leukocyte Common Antigens | 2 | 2017 | 50 | 0.140 |
Why?
|
| Weight Gain | 3 | 2014 | 128 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 51 | 0.140 |
Why?
|
| Trans-Activators | 3 | 2005 | 439 | 0.140 |
Why?
|
| DNA, Ribosomal | 3 | 2018 | 55 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2025 | 4565 | 0.140 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 44 | 0.140 |
Why?
|
| Membrane Fluidity | 1 | 1997 | 9 | 0.140 |
Why?
|
| Research | 1 | 2019 | 251 | 0.130 |
Why?
|
| Pelvic Exenteration | 1 | 2017 | 5 | 0.130 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2017 | 16 | 0.130 |
Why?
|
| Nutritional Status | 2 | 2018 | 79 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2020 | 243 | 0.130 |
Why?
|
| Case-Control Studies | 5 | 2025 | 1933 | 0.130 |
Why?
|
| Membrane Glycoproteins | 5 | 2009 | 443 | 0.130 |
Why?
|
| Kidney Medulla | 2 | 1994 | 77 | 0.130 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 198 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 254 | 0.130 |
Why?
|
| Fructose | 1 | 2017 | 36 | 0.130 |
Why?
|
| Gestational Age | 3 | 2025 | 334 | 0.130 |
Why?
|
| Kidney Tubules, Proximal | 2 | 1995 | 60 | 0.130 |
Why?
|
| Shear Strength | 1 | 2017 | 17 | 0.130 |
Why?
|
| Incidence | 3 | 2012 | 1702 | 0.130 |
Why?
|
| Fetal Weight | 1 | 2017 | 16 | 0.130 |
Why?
|
| Peripartum Period | 1 | 2017 | 29 | 0.130 |
Why?
|
| DNA, Antisense | 3 | 2003 | 15 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 4 | 2005 | 222 | 0.130 |
Why?
|
| Adipokines | 2 | 2016 | 18 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2017 | 122 | 0.130 |
Why?
|
| Brain | 3 | 2025 | 2375 | 0.130 |
Why?
|
| Lipids | 2 | 2016 | 278 | 0.130 |
Why?
|
| Sirtuins | 2 | 2017 | 79 | 0.130 |
Why?
|
| Prostatic Neoplasms | 3 | 2007 | 1775 | 0.130 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2016 | 14 | 0.130 |
Why?
|
| Ileitis | 1 | 2016 | 7 | 0.130 |
Why?
|
| Blood Coagulation | 1 | 2017 | 90 | 0.130 |
Why?
|
| Medicine, Traditional | 1 | 2016 | 8 | 0.130 |
Why?
|
| History, 21st Century | 2 | 2014 | 187 | 0.130 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 148 | 0.120 |
Why?
|
| Biological Factors | 1 | 2016 | 18 | 0.120 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2016 | 19 | 0.120 |
Why?
|
| Bifidobacterium breve | 1 | 2016 | 2 | 0.120 |
Why?
|
| Gene-Environment Interaction | 2 | 2015 | 120 | 0.120 |
Why?
|
| Ubiquitin | 2 | 2009 | 95 | 0.120 |
Why?
|
| RNA, Transfer | 1 | 2018 | 168 | 0.120 |
Why?
|
| Carotid Stenosis | 1 | 2017 | 114 | 0.120 |
Why?
|
| Streptomycin | 1 | 2016 | 5 | 0.120 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2016 | 12 | 0.120 |
Why?
|
| Immunotherapy | 2 | 2020 | 761 | 0.120 |
Why?
|
| Regional Blood Flow | 3 | 2015 | 186 | 0.120 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 98 | 0.120 |
Why?
|
| Interleukin-1 | 2 | 2001 | 71 | 0.120 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 1073 | 0.120 |
Why?
|
| Saponins | 1 | 2016 | 41 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 959 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2023 | 870 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 150 | 0.120 |
Why?
|
| Luciferases | 2 | 2008 | 129 | 0.120 |
Why?
|
| Penicillins | 1 | 2016 | 24 | 0.120 |
Why?
|
| Celiac Disease | 1 | 2019 | 219 | 0.120 |
Why?
|
| Research Design | 2 | 2018 | 620 | 0.120 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 101 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2017 | 106 | 0.120 |
Why?
|
| Fats | 1 | 2016 | 12 | 0.120 |
Why?
|
| Polyphenols | 1 | 2016 | 13 | 0.120 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 2 | 2013 | 13 | 0.120 |
Why?
|
| Lymphocyte Activation | 5 | 2015 | 797 | 0.120 |
Why?
|
| Mast Cells | 1 | 2016 | 96 | 0.120 |
Why?
|
| Yersinia Infections | 1 | 2016 | 5 | 0.120 |
Why?
|
| Leukocytes | 1 | 2017 | 210 | 0.120 |
Why?
|
| Cricetinae | 4 | 1997 | 532 | 0.120 |
Why?
|
| SUMO-1 Protein | 2 | 2013 | 15 | 0.120 |
Why?
|
| Plant Preparations | 1 | 2016 | 20 | 0.120 |
Why?
|
| Leukemia | 1 | 2018 | 301 | 0.120 |
Why?
|
| Yersinia enterocolitica | 1 | 2016 | 18 | 0.120 |
Why?
|
| Bethanechol Compounds | 2 | 1992 | 2 | 0.120 |
Why?
|
| Deoxyribonuclease I | 1 | 2015 | 27 | 0.120 |
Why?
|
| Ileus | 2 | 2013 | 14 | 0.120 |
Why?
|
| Indoles | 1 | 2017 | 301 | 0.120 |
Why?
|
| Contig Mapping | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Interleukin-1alpha | 1 | 2015 | 4 | 0.120 |
Why?
|
| Rutin | 1 | 2015 | 2 | 0.120 |
Why?
|
| Animals, Genetically Modified | 2 | 2013 | 186 | 0.120 |
Why?
|
| Immunity | 2 | 2015 | 153 | 0.120 |
Why?
|
| Butter | 1 | 2015 | 2 | 0.120 |
Why?
|
| Dietary Sucrose | 1 | 2015 | 14 | 0.120 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 123 | 0.120 |
Why?
|
| Lipogenesis | 1 | 2015 | 25 | 0.110 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 125 | 0.110 |
Why?
|
| Adenosine Triphosphate | 3 | 2014 | 315 | 0.110 |
Why?
|
| Anti-Obesity Agents | 1 | 2015 | 16 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2023 | 398 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2024 | 176 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2017 | 108 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 282 | 0.110 |
Why?
|
| Macrolides | 1 | 2015 | 30 | 0.110 |
Why?
|
| Mucin-2 | 1 | 2015 | 12 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 133 | 0.110 |
Why?
|
| Firmicutes | 1 | 2015 | 14 | 0.110 |
Why?
|
| Lubiprostone | 2 | 2013 | 3 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 103 | 0.110 |
Why?
|
| Palmitic Acid | 1 | 2015 | 29 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2025 | 917 | 0.110 |
Why?
|
| Enterocolitis, Necrotizing | 3 | 2013 | 82 | 0.110 |
Why?
|
| Biopsy | 2 | 2010 | 1177 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 86 | 0.110 |
Why?
|
| Fascia | 1 | 2015 | 32 | 0.110 |
Why?
|
| Pancreas | 2 | 2013 | 258 | 0.110 |
Why?
|
| Caspases | 3 | 2012 | 151 | 0.110 |
Why?
|
| Species Specificity | 2 | 2015 | 683 | 0.110 |
Why?
|
| Caenorhabditis elegans | 1 | 2017 | 245 | 0.110 |
Why?
|
| Dipeptides | 1 | 2015 | 39 | 0.110 |
Why?
|
| Biological Transport, Active | 5 | 2008 | 99 | 0.110 |
Why?
|
| Amelogenesis | 2 | 2012 | 2 | 0.110 |
Why?
|
| SLC4A Proteins | 2 | 2012 | 2 | 0.110 |
Why?
|
| Immunoprecipitation | 3 | 2014 | 136 | 0.110 |
Why?
|
| Cysteine Endopeptidases | 1 | 2015 | 87 | 0.110 |
Why?
|
| Viscosity | 1 | 2014 | 51 | 0.110 |
Why?
|
| Anion Transport Proteins | 2 | 2012 | 10 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 68 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 106 | 0.110 |
Why?
|
| Thiazoles | 1 | 2015 | 124 | 0.110 |
Why?
|
| Water-Electrolyte Balance | 2 | 1992 | 68 | 0.110 |
Why?
|
| Mitogens | 2 | 2005 | 59 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2019 | 296 | 0.110 |
Why?
|
| Dendritic Cells | 3 | 2020 | 536 | 0.110 |
Why?
|
| Precipitin Tests | 3 | 2004 | 101 | 0.110 |
Why?
|
| Environment | 1 | 2016 | 230 | 0.110 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 38 | 0.110 |
Why?
|
| Antidiarrheals | 2 | 2001 | 14 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 66 | 0.110 |
Why?
|
| Enteritis | 1 | 2014 | 23 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 75 | 0.100 |
Why?
|
| Binding Sites | 3 | 2012 | 1128 | 0.100 |
Why?
|
| Physical Conditioning, Animal | 1 | 2014 | 18 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2015 | 120 | 0.100 |
Why?
|
| Immunization | 1 | 2014 | 154 | 0.100 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 77 | 0.100 |
Why?
|
| Gene Targeting | 1 | 2014 | 74 | 0.100 |
Why?
|
| Famous Persons | 1 | 2014 | 8 | 0.100 |
Why?
|
| Potassium | 2 | 2001 | 232 | 0.100 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 46 | 0.100 |
Why?
|
| DNA | 4 | 2004 | 1260 | 0.100 |
Why?
|
| High Mobility Group Proteins | 1 | 2013 | 27 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2017 | 355 | 0.100 |
Why?
|
| Enterocytes | 2 | 2025 | 27 | 0.100 |
Why?
|
| Flavonoids | 1 | 2014 | 85 | 0.100 |
Why?
|
| Airway Remodeling | 1 | 2013 | 10 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2020 | 812 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2017 | 83 | 0.100 |
Why?
|
| Cell Polarity | 2 | 2009 | 118 | 0.100 |
Why?
|
| Adenomatous Polyps | 1 | 2013 | 15 | 0.100 |
Why?
|
| Nucleosomes | 1 | 2013 | 61 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 50 | 0.100 |
Why?
|
| Thapsigargin | 2 | 2007 | 55 | 0.100 |
Why?
|
| Carrageenan | 1 | 2013 | 9 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 131 | 0.100 |
Why?
|
| Allergens | 1 | 2014 | 189 | 0.100 |
Why?
|
| B7-H1 Antigen | 1 | 2015 | 305 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 2 | 2010 | 292 | 0.100 |
Why?
|
| Immune System | 1 | 2014 | 101 | 0.100 |
Why?
|
| Gonads | 1 | 2013 | 18 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2014 | 314 | 0.100 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2014 | 91 | 0.100 |
Why?
|
| Muscle, Smooth | 2 | 1991 | 300 | 0.100 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2009 | 46 | 0.100 |
Why?
|
| Sodium Chloride | 1 | 1993 | 84 | 0.100 |
Why?
|
| Mice, Inbred CFTR | 1 | 2013 | 4 | 0.100 |
Why?
|
| Hemorheology | 1 | 2013 | 8 | 0.100 |
Why?
|
| Pancreatitis | 1 | 2013 | 94 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 79 | 0.100 |
Why?
|
| Mesentery | 1 | 2013 | 46 | 0.100 |
Why?
|
| Hippocampus | 1 | 1996 | 452 | 0.100 |
Why?
|
| Infant Mortality | 1 | 2013 | 66 | 0.100 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2012 | 6 | 0.100 |
Why?
|
| Response Elements | 2 | 2011 | 65 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 148 | 0.090 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 72 | 0.090 |
Why?
|
| Monocytes | 1 | 2014 | 215 | 0.090 |
Why?
|
| Infant | 4 | 2024 | 3222 | 0.090 |
Why?
|
| Rats, Inbred Strains | 6 | 1992 | 303 | 0.090 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2012 | 25 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 147 | 0.090 |
Why?
|
| Receptors, Adrenergic | 2 | 1983 | 14 | 0.090 |
Why?
|
| Transgenes | 1 | 2013 | 171 | 0.090 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2022 | 10 | 0.090 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2002 | 20 | 0.090 |
Why?
|
| Sucrase | 1 | 1992 | 2 | 0.090 |
Why?
|
| Lactobacillus | 2 | 2018 | 23 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 160 | 0.090 |
Why?
|
| Taurine | 1 | 2012 | 10 | 0.090 |
Why?
|
| Choroid | 2 | 2022 | 22 | 0.090 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 306 | 0.090 |
Why?
|
| Lymphotoxin-alpha | 1 | 2012 | 41 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 237 | 0.090 |
Why?
|
| Receptors, Oxytocin | 1 | 2012 | 10 | 0.090 |
Why?
|
| Molecular Weight | 5 | 2009 | 279 | 0.090 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 154 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 91 | 0.090 |
Why?
|
| Uterine Contraction | 1 | 2012 | 8 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2017 | 46 | 0.090 |
Why?
|
| United States | 3 | 2025 | 7645 | 0.090 |
Why?
|
| 3T3 Cells | 2 | 2003 | 94 | 0.090 |
Why?
|
| Sodium Radioisotopes | 2 | 2009 | 2 | 0.090 |
Why?
|
| Survivors | 2 | 2023 | 204 | 0.090 |
Why?
|
| Pituitary Diseases | 1 | 2012 | 6 | 0.090 |
Why?
|
| Body Composition | 2 | 2012 | 75 | 0.090 |
Why?
|
| Caspase 9 | 2 | 2002 | 47 | 0.090 |
Why?
|
| CD3 Complex | 4 | 2014 | 135 | 0.090 |
Why?
|
| Central Nervous System Cysts | 1 | 2012 | 9 | 0.090 |
Why?
|
| Sulfites | 1 | 2012 | 32 | 0.090 |
Why?
|
| Ovariectomy | 1 | 2012 | 91 | 0.090 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2012 | 11 | 0.090 |
Why?
|
| Androgen Antagonists | 2 | 2003 | 143 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 309 | 0.090 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 99 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 122 | 0.090 |
Why?
|
| Sigmoidoscopy | 1 | 2012 | 37 | 0.090 |
Why?
|
| Ion Channels | 2 | 1991 | 256 | 0.090 |
Why?
|
| Organogenesis | 1 | 2012 | 50 | 0.090 |
Why?
|
| Connexin 43 | 1 | 2012 | 94 | 0.090 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 135 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2012 | 63 | 0.090 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 554 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2009 | 40 | 0.090 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 226 | 0.090 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 183 | 0.090 |
Why?
|
| Visual Acuity | 2 | 2023 | 209 | 0.090 |
Why?
|
| Heart Failure | 1 | 2022 | 1388 | 0.090 |
Why?
|
| Pectins | 2 | 2001 | 5 | 0.090 |
Why?
|
| Lymphocytes | 2 | 2004 | 454 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 379 | 0.090 |
Why?
|
| Pesticide Residues | 1 | 2011 | 2 | 0.090 |
Why?
|
| Pituitary Neoplasms | 1 | 2012 | 73 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 304 | 0.090 |
Why?
|
| Solid Phase Extraction | 1 | 2011 | 14 | 0.090 |
Why?
|
| Birth Weight | 2 | 2025 | 150 | 0.090 |
Why?
|
| Eflornithine | 1 | 2011 | 17 | 0.090 |
Why?
|
| Genome | 1 | 2014 | 407 | 0.090 |
Why?
|
| Metabolomics | 2 | 2025 | 98 | 0.090 |
Why?
|
| Calcification, Physiologic | 1 | 2011 | 33 | 0.090 |
Why?
|
| Melanoma | 1 | 2015 | 495 | 0.080 |
Why?
|
| Food Contamination | 1 | 2011 | 35 | 0.080 |
Why?
|
| Proto-Oncogenes | 1 | 2011 | 60 | 0.080 |
Why?
|
| Rats, Inbred Lew | 5 | 2020 | 214 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 44 | 0.080 |
Why?
|
| Dissection | 1 | 2011 | 45 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2025 | 896 | 0.080 |
Why?
|
| Collagen | 2 | 2019 | 300 | 0.080 |
Why?
|
| Arachidonate Lipoxygenases | 1 | 1990 | 1 | 0.080 |
Why?
|
| Light | 2 | 2022 | 287 | 0.080 |
Why?
|
| Hydrogen | 2 | 1988 | 53 | 0.080 |
Why?
|
| Software | 1 | 2015 | 670 | 0.080 |
Why?
|
| Plaque, Amyloid | 2 | 2024 | 66 | 0.080 |
Why?
|
| Administration, Oral | 3 | 2024 | 657 | 0.080 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 1990 | 21 | 0.080 |
Why?
|
| Organ Size | 3 | 2020 | 361 | 0.080 |
Why?
|
| Antibodies | 2 | 2021 | 347 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1715 | 0.080 |
Why?
|
| Korea | 1 | 2010 | 18 | 0.080 |
Why?
|
| Uterus | 1 | 2012 | 225 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 38 | 0.080 |
Why?
|
| Tissue Distribution | 3 | 2010 | 290 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 41 | 0.080 |
Why?
|
| Arachidonic Acids | 1 | 1990 | 36 | 0.080 |
Why?
|
| Interleukin-3 | 1 | 1990 | 39 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2023 | 291 | 0.080 |
Why?
|
| Clostridium | 2 | 2024 | 24 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2013 | 443 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 620 | 0.080 |
Why?
|
| Human Experimentation | 1 | 2010 | 39 | 0.080 |
Why?
|
| Water | 2 | 2006 | 306 | 0.080 |
Why?
|
| Galvanic Skin Response | 1 | 2010 | 12 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 481 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 1923 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 306 | 0.080 |
Why?
|
| T-Cell Intracellular Antigen-1 | 1 | 2010 | 5 | 0.080 |
Why?
|
| Claudin-1 | 1 | 2010 | 17 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2010 | 18 | 0.080 |
Why?
|
| Parietal Cells, Gastric | 1 | 1990 | 1 | 0.080 |
Why?
|
| Gastric Acid | 1 | 1990 | 5 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2010 | 18 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2025 | 920 | 0.080 |
Why?
|
| Cytoskeleton | 2 | 2003 | 198 | 0.080 |
Why?
|
| Phosphatidylinositols | 1 | 1990 | 19 | 0.080 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 12 | 0.080 |
Why?
|
| Ribonucleoproteins | 1 | 2010 | 36 | 0.080 |
Why?
|
| Interleukins | 3 | 2016 | 133 | 0.080 |
Why?
|
| Absorption | 3 | 1998 | 26 | 0.080 |
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2024 | 50 | 0.080 |
Why?
|
| Salmonella | 1 | 1989 | 14 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 20 | 0.080 |
Why?
|
| eIF-2 Kinase | 1 | 2010 | 50 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 74 | 0.080 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2009 | 41 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1992 | 16 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 52 | 0.080 |
Why?
|
| ras Proteins | 1 | 1990 | 132 | 0.080 |
Why?
|
| Methylation | 2 | 2022 | 288 | 0.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 58 | 0.070 |
Why?
|
| Gene Expression Regulation, Bacterial | 3 | 2012 | 204 | 0.070 |
Why?
|
| Phosphoserine | 1 | 2009 | 9 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 1990 | 102 | 0.070 |
Why?
|
| Dogs | 5 | 2005 | 634 | 0.070 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2009 | 21 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2718 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 100 | 0.070 |
Why?
|
| Pregnancy Complications | 2 | 2013 | 352 | 0.070 |
Why?
|
| Losartan | 1 | 2009 | 29 | 0.070 |
Why?
|
| Intestinal Secretions | 1 | 1989 | 1 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 269 | 0.070 |
Why?
|
| Curcumin | 2 | 2014 | 16 | 0.070 |
Why?
|
| Radiation-Protective Agents | 1 | 2009 | 98 | 0.070 |
Why?
|
| Cholera Toxin | 1 | 1989 | 21 | 0.070 |
Why?
|
| Receptor, Insulin | 1 | 2009 | 60 | 0.070 |
Why?
|
| Niflumic Acid | 1 | 2008 | 1 | 0.070 |
Why?
|
| Methazolamide | 1 | 2008 | 3 | 0.070 |
Why?
|
| Perforin | 1 | 2009 | 56 | 0.070 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2008 | 17 | 0.070 |
Why?
|
| Phorbol Esters | 2 | 1985 | 19 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 121 | 0.070 |
Why?
|
| Proteins | 3 | 2008 | 800 | 0.070 |
Why?
|
| Bronchi | 1 | 2010 | 225 | 0.070 |
Why?
|
| Clathrin | 1 | 2008 | 31 | 0.070 |
Why?
|
| Milk Proteins | 1 | 2008 | 24 | 0.070 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2008 | 10 | 0.070 |
Why?
|
| Calmodulin | 1 | 1989 | 50 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 98 | 0.070 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2008 | 45 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 2 | 2005 | 715 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2011 | 506 | 0.070 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 284 | 0.070 |
Why?
|
| Calcium, Dietary | 1 | 2008 | 68 | 0.070 |
Why?
|
| Bacillus anthracis | 1 | 2009 | 73 | 0.070 |
Why?
|
| Peptides | 4 | 2023 | 654 | 0.070 |
Why?
|
| Isomerism | 3 | 1999 | 27 | 0.070 |
Why?
|
| Guanidines | 2 | 1998 | 30 | 0.070 |
Why?
|
| Membrane Potentials | 3 | 2001 | 405 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2023 | 376 | 0.070 |
Why?
|
| Somatostatin | 1 | 1988 | 58 | 0.070 |
Why?
|
| Cell Size | 2 | 2001 | 71 | 0.070 |
Why?
|
| Sulfones | 2 | 1998 | 47 | 0.070 |
Why?
|
| Endoscopy | 1 | 2012 | 366 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 385 | 0.070 |
Why?
|
| Hydrolases | 2 | 2002 | 29 | 0.070 |
Why?
|
| Glycosylation | 4 | 2002 | 134 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 1989 | 112 | 0.070 |
Why?
|
| Dactinomycin | 1 | 2008 | 32 | 0.070 |
Why?
|
| DNA, Mitochondrial | 2 | 2021 | 200 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 106 | 0.070 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2008 | 10 | 0.070 |
Why?
|
| Gastroparesis | 1 | 2008 | 16 | 0.070 |
Why?
|
| Weight Loss | 2 | 2022 | 234 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2005 | 602 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2005 | 85 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 7073 | 0.070 |
Why?
|
| Shock | 1 | 2007 | 46 | 0.070 |
Why?
|
| Spores, Bacterial | 1 | 2007 | 18 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1165 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2009 | 162 | 0.060 |
Why?
|
| Dynorphins | 1 | 2007 | 14 | 0.060 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2007 | 27 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 214 | 0.060 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 3 | 1992 | 13 | 0.060 |
Why?
|
| Solubility | 2 | 2009 | 186 | 0.060 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 1985 | 53 | 0.060 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2006 | 5 | 0.060 |
Why?
|
| Syndrome | 1 | 2007 | 437 | 0.060 |
Why?
|
| Piroxicam | 3 | 1991 | 11 | 0.060 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2006 | 10 | 0.060 |
Why?
|
| Chinchilla | 1 | 1986 | 4 | 0.060 |
Why?
|
| Gastroplasty | 1 | 2006 | 27 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 1988 | 250 | 0.060 |
Why?
|
| Hepatectomy | 3 | 2003 | 177 | 0.060 |
Why?
|
| Cricetulus | 2 | 1997 | 122 | 0.060 |
Why?
|
| Adolescent | 2 | 2016 | 9610 | 0.060 |
Why?
|
| Electric Conductivity | 3 | 1992 | 142 | 0.060 |
Why?
|
| Yohimbine | 2 | 1983 | 6 | 0.060 |
Why?
|
| Mammals | 2 | 2022 | 259 | 0.060 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2006 | 40 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 111 | 0.060 |
Why?
|
| Binding, Competitive | 4 | 2012 | 136 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2007 | 289 | 0.060 |
Why?
|
| Phorbols | 1 | 1985 | 5 | 0.060 |
Why?
|
| Esophagogastric Junction | 1 | 2006 | 35 | 0.060 |
Why?
|
| Aminoquinolines | 2 | 2001 | 20 | 0.060 |
Why?
|
| Short Bowel Syndrome | 1 | 2006 | 37 | 0.060 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2025 | 12 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2006 | 190 | 0.060 |
Why?
|
| I-kappa B Proteins | 2 | 2005 | 47 | 0.060 |
Why?
|
| Porins | 1 | 2005 | 24 | 0.060 |
Why?
|
| Esophagostomy | 1 | 2005 | 1 | 0.060 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2008 | 242 | 0.060 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2005 | 27 | 0.060 |
Why?
|
| Gastric Fundus | 1 | 2005 | 7 | 0.060 |
Why?
|
| Receptors, CXCR4 | 1 | 2005 | 49 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2008 | 168 | 0.060 |
Why?
|
| Trachea | 2 | 2019 | 245 | 0.060 |
Why?
|
| Phenylhydrazines | 1 | 2005 | 9 | 0.060 |
Why?
|
| Intestinal Neoplasms | 1 | 2006 | 68 | 0.060 |
Why?
|
| Fundoplication | 1 | 2006 | 73 | 0.060 |
Why?
|
| Carcinogens | 1 | 1985 | 101 | 0.060 |
Why?
|
| Endosonography | 1 | 2006 | 100 | 0.060 |
Why?
|
| Complement Activation | 1 | 2025 | 84 | 0.060 |
Why?
|
| Piperidines | 1 | 1986 | 165 | 0.060 |
Why?
|
| Immunoassay | 1 | 2025 | 99 | 0.060 |
Why?
|
| RNA Precursors | 1 | 2005 | 73 | 0.050 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 5 | 0.050 |
Why?
|
| Fermentation | 1 | 2004 | 15 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2005 | 71 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2025 | 136 | 0.050 |
Why?
|
| Gastrostomy | 1 | 2005 | 66 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 52 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2024 | 77 | 0.050 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2004 | 3 | 0.050 |
Why?
|
| Bacteriophages | 1 | 2024 | 42 | 0.050 |
Why?
|
| Camptothecin | 1 | 2005 | 196 | 0.050 |
Why?
|
| Mannitol | 3 | 2001 | 49 | 0.050 |
Why?
|
| Bradykinin | 2 | 1996 | 44 | 0.050 |
Why?
|
| Tetramethylphenylenediamine | 1 | 2004 | 1 | 0.050 |
Why?
|
| Cimetidine | 1 | 2004 | 6 | 0.050 |
Why?
|
| Conjugation, Genetic | 1 | 2024 | 18 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2024 | 20 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2004 | 32 | 0.050 |
Why?
|
| Vipoma | 1 | 1983 | 5 | 0.050 |
Why?
|
| Arterial Pressure | 1 | 2024 | 41 | 0.050 |
Why?
|
| Adenoma, Islet Cell | 1 | 1983 | 28 | 0.050 |
Why?
|
| Heptanes | 1 | 2003 | 2 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2005 | 220 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 246 | 0.050 |
Why?
|
| Trypsin | 1 | 2004 | 90 | 0.050 |
Why?
|
| Amines | 1 | 2024 | 31 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1994 | 238 | 0.050 |
Why?
|
| Amides | 1 | 2024 | 54 | 0.050 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 2 | 1996 | 14 | 0.050 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2003 | 23 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2017 | 304 | 0.050 |
Why?
|
| Protective Agents | 1 | 2004 | 34 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 57 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 502 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 244 | 0.050 |
Why?
|
| Head | 1 | 2024 | 131 | 0.050 |
Why?
|
| Colony Count, Microbial | 2 | 2014 | 40 | 0.050 |
Why?
|
| Pyloric Antrum | 1 | 2003 | 4 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2024 | 86 | 0.050 |
Why?
|
| Catalysis | 1 | 2024 | 216 | 0.050 |
Why?
|
| Epilepsy | 1 | 2008 | 434 | 0.050 |
Why?
|
| Receptors, Interleukin-11 | 1 | 2003 | 1 | 0.050 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2003 | 1 | 0.050 |
Why?
|
| Octoxynol | 1 | 2003 | 8 | 0.050 |
Why?
|
| Amyloid | 1 | 2024 | 104 | 0.050 |
Why?
|
| Detergents | 1 | 2003 | 31 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2014 | 884 | 0.050 |
Why?
|
| Metronidazole | 1 | 2003 | 26 | 0.050 |
Why?
|
| Prostate | 1 | 2007 | 416 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2014 | 712 | 0.050 |
Why?
|
| Methotrexate | 1 | 2004 | 225 | 0.050 |
Why?
|
| Receptors, Interleukin | 1 | 2003 | 38 | 0.050 |
Why?
|
| Triglycerides | 2 | 2016 | 231 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2023 | 6 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 198 | 0.050 |
Why?
|
| DNA Transposable Elements | 1 | 2024 | 168 | 0.050 |
Why?
|
| Leukocyte Rolling | 2 | 2012 | 2 | 0.050 |
Why?
|
| Densitometry | 1 | 2003 | 23 | 0.050 |
Why?
|
| Colforsin | 3 | 2003 | 68 | 0.050 |
Why?
|
| Morphine | 1 | 1984 | 128 | 0.050 |
Why?
|
| Cesarean Section | 1 | 2024 | 158 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2003 | 102 | 0.050 |
Why?
|
| Amino Acids | 1 | 2024 | 246 | 0.050 |
Why?
|
| CD28 Antigens | 1 | 2003 | 94 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 3 | 2012 | 726 | 0.050 |
Why?
|
| Bethanechol | 2 | 1992 | 2 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 451 | 0.050 |
Why?
|
| Base Sequence | 4 | 2012 | 2209 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2003 | 43 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 603 | 0.050 |
Why?
|
| Darkness | 1 | 2022 | 47 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2023 | 161 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2003 | 60 | 0.050 |
Why?
|
| Body Temperature Regulation | 1 | 2022 | 59 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2002 | 87 | 0.050 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2003 | 158 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 292 | 0.050 |
Why?
|
| Motivation | 1 | 2025 | 310 | 0.050 |
Why?
|
| Hydrostatic Pressure | 1 | 2022 | 5 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 195 | 0.050 |
Why?
|
| Stimulation, Chemical | 2 | 1993 | 55 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 1449 | 0.040 |
Why?
|
| Anastomotic Leak | 1 | 2023 | 109 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2003 | 146 | 0.040 |
Why?
|
| Virus Inactivation | 1 | 2021 | 4 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2021 | 18 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 2021 | 16 | 0.040 |
Why?
|
| Semiconductors | 1 | 2021 | 12 | 0.040 |
Why?
|
| Thiadiazoles | 1 | 2021 | 12 | 0.040 |
Why?
|
| Meconium | 2 | 2013 | 15 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 37 | 0.040 |
Why?
|
| DNA Damage | 2 | 2014 | 389 | 0.040 |
Why?
|
| Photoperiod | 1 | 2022 | 73 | 0.040 |
Why?
|
| Thionucleotides | 2 | 1999 | 54 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2021 | 67 | 0.040 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2001 | 3 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 74 | 0.040 |
Why?
|
| Histones | 2 | 2014 | 361 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2022 | 86 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 109 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 76 | 0.040 |
Why?
|
| Cyclic AMP Response Element Modulator | 2 | 2012 | 3 | 0.040 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 82 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 59 | 0.040 |
Why?
|
| Mastectomy | 1 | 2023 | 262 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 2001 | 15 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2005 | 1061 | 0.040 |
Why?
|
| Ammonia | 1 | 2001 | 35 | 0.040 |
Why?
|
| Lasers | 1 | 2021 | 101 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 3835 | 0.040 |
Why?
|
| Spermine | 1 | 2001 | 25 | 0.040 |
Why?
|
| Ouabain | 1 | 2001 | 24 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2021 | 56 | 0.040 |
Why?
|
| Arachidonic Acid | 2 | 1992 | 62 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2002 | 209 | 0.040 |
Why?
|
| Iron Chelating Agents | 1 | 2001 | 4 | 0.040 |
Why?
|
| Rubidium Radioisotopes | 1 | 2001 | 4 | 0.040 |
Why?
|
| Muscles | 2 | 2014 | 184 | 0.040 |
Why?
|
| Fatigue | 1 | 2022 | 181 | 0.040 |
Why?
|
| Bicarbonates | 2 | 1995 | 58 | 0.040 |
Why?
|
| HCT116 Cells | 2 | 2015 | 162 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2019 | 485 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 758 | 0.040 |
Why?
|
| Ontario | 1 | 2020 | 31 | 0.040 |
Why?
|
| Theophylline | 2 | 1992 | 34 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2022 | 123 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2024 | 372 | 0.040 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2020 | 3 | 0.040 |
Why?
|
| Liver X Receptors | 1 | 2020 | 15 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 5 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2001 | 137 | 0.040 |
Why?
|
| Breast Density | 1 | 2020 | 42 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 108 | 0.040 |
Why?
|
| Infant, Premature | 2 | 2015 | 297 | 0.040 |
Why?
|
| Polymers | 1 | 2021 | 218 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2020 | 83 | 0.040 |
Why?
|
| Cell Fractionation | 2 | 2004 | 64 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2002 | 337 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2012 | 1354 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2020 | 91 | 0.040 |
Why?
|
| Vancomycin | 1 | 2020 | 75 | 0.040 |
Why?
|
| Carbachol | 3 | 1990 | 35 | 0.040 |
Why?
|
| Cholestasis | 1 | 2020 | 44 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2019 | 37 | 0.040 |
Why?
|
| Face | 1 | 2020 | 109 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2020 | 137 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2020 | 49 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 32 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1985 | 589 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 63 | 0.040 |
Why?
|
| Home Care Services | 1 | 2020 | 77 | 0.040 |
Why?
|
| Substance P | 3 | 1990 | 62 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 1997 | 379 | 0.040 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2019 | 10 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 155 | 0.040 |
Why?
|
| Patients | 1 | 2020 | 104 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1999 | 65 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2015 | 1119 | 0.040 |
Why?
|
| Enterococcus faecalis | 1 | 2019 | 57 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2020 | 160 | 0.040 |
Why?
|
| Patient Dropouts | 1 | 2019 | 31 | 0.040 |
Why?
|
| Streptozocin | 2 | 2017 | 56 | 0.040 |
Why?
|
| Peroxidase | 1 | 2019 | 54 | 0.040 |
Why?
|
| ARNTL Transcription Factors | 1 | 2018 | 13 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1999 | 26 | 0.040 |
Why?
|
| PPAR alpha | 1 | 2018 | 8 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2020 | 164 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 238 | 0.040 |
Why?
|
| Chick Embryo | 1 | 1999 | 176 | 0.040 |
Why?
|
| Hypertonic Solutions | 2 | 1999 | 17 | 0.040 |
Why?
|
| Mitochondria | 1 | 2002 | 612 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 53 | 0.040 |
Why?
|
| Calcimycin | 2 | 1990 | 32 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 66 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2020 | 348 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2001 | 346 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 1998 | 39 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 1056 | 0.040 |
Why?
|
| Mineralocorticoids | 1 | 1998 | 7 | 0.030 |
Why?
|
| Radiography | 2 | 2013 | 790 | 0.030 |
Why?
|
| Penetrance | 1 | 2018 | 48 | 0.030 |
Why?
|
| RNA Stability | 1 | 2018 | 97 | 0.030 |
Why?
|
| Imidazoles | 2 | 1990 | 138 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2009 | 31 | 0.030 |
Why?
|
| Benzyl Alcohol | 1 | 1997 | 3 | 0.030 |
Why?
|
| Trifluoperazine | 2 | 1989 | 10 | 0.030 |
Why?
|
| Sodium Salicylate | 1 | 1997 | 4 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 281 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2018 | 82 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 315 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2019 | 137 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2017 | 13 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2020 | 494 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2001 | 69 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2012 | 1525 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2024 | 3832 | 0.030 |
Why?
|
| Genistein | 1 | 2017 | 16 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2018 | 351 | 0.030 |
Why?
|
| Growth Charts | 1 | 2017 | 2 | 0.030 |
Why?
|
| Ammonium Chloride | 2 | 1996 | 22 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2017 | 65 | 0.030 |
Why?
|
| Catalase | 1 | 2017 | 46 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2018 | 131 | 0.030 |
Why?
|
| Diazooxonorleucine | 1 | 1997 | 7 | 0.030 |
Why?
|
| Endarterectomy, Carotid | 1 | 2017 | 75 | 0.030 |
Why?
|
| Heart Rate | 1 | 2020 | 508 | 0.030 |
Why?
|
| Methyltransferases | 1 | 2018 | 213 | 0.030 |
Why?
|
| Genes, Bacterial | 2 | 2012 | 150 | 0.030 |
Why?
|
| Superoxides | 1 | 2017 | 75 | 0.030 |
Why?
|
| Plant Roots | 1 | 2017 | 112 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 1996 | 8 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2020 | 548 | 0.030 |
Why?
|
| Lactobacillaceae | 1 | 2016 | 2 | 0.030 |
Why?
|
| Mammography | 1 | 2020 | 494 | 0.030 |
Why?
|
| Inactivation, Metabolic | 1 | 2016 | 9 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2016 | 29 | 0.030 |
Why?
|
| Telomerase | 1 | 2017 | 67 | 0.030 |
Why?
|
| Muscle Denervation | 1 | 1996 | 3 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2025 | 2484 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 578 | 0.030 |
Why?
|
| Manometry | 2 | 2007 | 42 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2017 | 85 | 0.030 |
Why?
|
| Malabsorption Syndromes | 1 | 1996 | 21 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1998 | 517 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 295 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 111 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2019 | 298 | 0.030 |
Why?
|
| Tunicamycin | 1 | 1996 | 10 | 0.030 |
Why?
|
| Lymphatic System | 1 | 1996 | 54 | 0.030 |
Why?
|
| Pyocyanine | 2 | 2007 | 12 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2016 | 82 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 1996 | 57 | 0.030 |
Why?
|
| Dihydrolipoamide Dehydrogenase | 1 | 1996 | 2 | 0.030 |
Why?
|
| Leptin | 1 | 2016 | 100 | 0.030 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 1996 | 3 | 0.030 |
Why?
|
| Captopril | 1 | 1996 | 22 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 938 | 0.030 |
Why?
|
| Didelphis | 2 | 2006 | 4 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2017 | 112 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 1996 | 49 | 0.030 |
Why?
|
| Ligation | 2 | 2006 | 54 | 0.030 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1907 | 0.030 |
Why?
|
| Thermogenesis | 1 | 2016 | 46 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 875 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2016 | 31 | 0.030 |
Why?
|
| Ions | 1 | 1996 | 78 | 0.030 |
Why?
|
| Mitochondrial Size | 1 | 2015 | 4 | 0.030 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2015 | 9 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2015 | 49 | 0.030 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 1996 | 45 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 121 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 221 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1996 | 271 | 0.030 |
Why?
|
| Genes, myc | 1 | 2015 | 37 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2017 | 257 | 0.030 |
Why?
|
| Computing Methodologies | 1 | 2015 | 8 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1995 | 24 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2015 | 23 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 95 | 0.030 |
Why?
|
| Publishing | 1 | 1996 | 91 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2015 | 109 | 0.030 |
Why?
|
| Microsomes | 1 | 1994 | 32 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 79 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 2 | 2004 | 4 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 168 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 107 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1994 | 29 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 1994 | 41 | 0.030 |
Why?
|
| Peptide Hormones | 2 | 2005 | 30 | 0.030 |
Why?
|
| Foam Cells | 1 | 2014 | 17 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 1996 | 365 | 0.030 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 58 | 0.030 |
Why?
|
| CD18 Antigens | 1 | 2014 | 22 | 0.030 |
Why?
|
| Glucose Transporter Type 5 | 1 | 1994 | 6 | 0.030 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2014 | 24 | 0.030 |
Why?
|
| Glucose Transporter Type 2 | 1 | 1994 | 12 | 0.030 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2014 | 29 | 0.030 |
Why?
|
| Ceruletide | 1 | 2013 | 1 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 279 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 1996 | 168 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2014 | 54 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2014 | 16 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 828 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2004 | 277 | 0.030 |
Why?
|
| Diamide | 1 | 1993 | 3 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 233 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2014 | 87 | 0.020 |
Why?
|
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2013 | 8 | 0.020 |
Why?
|
| Radioisotopes | 1 | 1993 | 39 | 0.020 |
Why?
|
| Arginine | 1 | 2013 | 140 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 1993 | 12 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2014 | 133 | 0.020 |
Why?
|
| Nitrites | 1 | 1993 | 34 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 25 | 0.020 |
Why?
|
| E-Selectin | 1 | 2013 | 31 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 1993 | 67 | 0.020 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2012 | 25 | 0.020 |
Why?
|
| Chlorine | 1 | 1992 | 8 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 1993 | 98 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 253 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2012 | 6 | 0.020 |
Why?
|
| HLA-B27 Antigen | 1 | 2012 | 8 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2012 | 34 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 554 | 0.020 |
Why?
|
| Food Deprivation | 1 | 1992 | 23 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 1992 | 69 | 0.020 |
Why?
|
| Thymidine | 1 | 1992 | 58 | 0.020 |
Why?
|
| Hyperphagia | 1 | 1992 | 35 | 0.020 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2012 | 8 | 0.020 |
Why?
|
| Sphenoid Sinus | 1 | 2012 | 8 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1992 | 112 | 0.020 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2012 | 21 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 315 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 164 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1994 | 362 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 128 | 0.020 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2012 | 83 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 174 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2012 | 60 | 0.020 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2012 | 21 | 0.020 |
Why?
|
| Nucleotides, Cyclic | 1 | 1992 | 12 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1992 | 28 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 125 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2012 | 154 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 78 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1991 | 84 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 841 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2012 | 98 | 0.020 |
Why?
|
| Histamine | 1 | 1992 | 116 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 101 | 0.020 |
Why?
|
| DNA Probes | 1 | 1991 | 66 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 162 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 657 | 0.020 |
Why?
|
| Methionine | 1 | 1991 | 64 | 0.020 |
Why?
|
| DNA Replication | 1 | 1992 | 168 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 359 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2012 | 191 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 660 | 0.020 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 1 | 1990 | 1 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1723 | 0.020 |
Why?
|
| Isoquinolines | 1 | 1990 | 57 | 0.020 |
Why?
|
| Mucus | 1 | 2010 | 19 | 0.020 |
Why?
|
| Myristoylated Alanine-Rich C Kinase Substrate | 1 | 1990 | 3 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 103 | 0.020 |
Why?
|
| Acylation | 1 | 1990 | 68 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 3061 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 515 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 1990 | 16 | 0.020 |
Why?
|
| Exons | 1 | 1991 | 448 | 0.020 |
Why?
|
| Pancreatic Diseases | 1 | 2010 | 58 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 264 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 1990 | 145 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 30 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 576 | 0.020 |
Why?
|
| Ionomycin | 1 | 2009 | 19 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2009 | 38 | 0.020 |
Why?
|
| Bacteriocins | 1 | 2009 | 12 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2009 | 66 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2009 | 77 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 2009 | 32 | 0.020 |
Why?
|
| Reoperation | 1 | 2012 | 703 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2009 | 100 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1990 | 178 | 0.020 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2008 | 7 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2009 | 94 | 0.020 |
Why?
|
| Whey Proteins | 1 | 2008 | 8 | 0.020 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2008 | 6 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 45 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 67 | 0.020 |
Why?
|
| Hypothermia, Induced | 1 | 2009 | 90 | 0.020 |
Why?
|
| Ketoconazole | 1 | 2008 | 23 | 0.020 |
Why?
|
| Calcium Channels | 1 | 1990 | 180 | 0.020 |
Why?
|
| Sucrose | 1 | 2008 | 63 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1988 | 43 | 0.020 |
Why?
|
| Octreotide | 1 | 1988 | 29 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 337 | 0.020 |
Why?
|
| Electrophysiology | 2 | 1993 | 390 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 327 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2009 | 191 | 0.020 |
Why?
|
| Overweight | 1 | 2008 | 120 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1990 | 910 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 520 | 0.020 |
Why?
|
| Nigericin | 1 | 1987 | 2 | 0.020 |
Why?
|
| Valinomycin | 1 | 1987 | 8 | 0.020 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2007 | 10 | 0.020 |
Why?
|
| Buffers | 1 | 1987 | 24 | 0.020 |
Why?
|
| Defecation | 1 | 2007 | 26 | 0.020 |
Why?
|
| Peristalsis | 1 | 2006 | 10 | 0.020 |
Why?
|
| Cathartics | 1 | 2007 | 27 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 572 | 0.020 |
Why?
|
| Chloride Channels | 1 | 2007 | 43 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2008 | 98 | 0.020 |
Why?
|
| Chelating Agents | 1 | 1987 | 68 | 0.020 |
Why?
|
| Glycine | 1 | 1987 | 93 | 0.020 |
Why?
|
| Action Potentials | 1 | 1990 | 581 | 0.020 |
Why?
|
| Inosine | 1 | 2006 | 18 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2002 | 476 | 0.020 |
Why?
|
| Gallopamil | 1 | 1986 | 1 | 0.020 |
Why?
|
| Bombesin | 1 | 1986 | 6 | 0.020 |
Why?
|
| Denervation | 1 | 1986 | 25 | 0.020 |
Why?
|
| Neurotensin | 1 | 1986 | 10 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2007 | 154 | 0.020 |
Why?
|
| Echocardiography | 1 | 2010 | 748 | 0.010 |
Why?
|
| Pressure | 1 | 2006 | 166 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 187 | 0.010 |
Why?
|
| Gastroepiploic Artery | 1 | 2005 | 1 | 0.010 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2005 | 19 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2005 | 4 | 0.010 |
Why?
|
| Stomach | 1 | 2006 | 113 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2005 | 38 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2006 | 293 | 0.010 |
Why?
|
| Phosphothreonine | 1 | 2004 | 4 | 0.010 |
Why?
|
| fas Receptor | 1 | 2005 | 73 | 0.010 |
Why?
|
| Atrophy | 1 | 2005 | 128 | 0.010 |
Why?
|
| Aorta | 1 | 2006 | 273 | 0.010 |
Why?
|
| Narcotics | 1 | 1985 | 72 | 0.010 |
Why?
|
| Morphine Dependence | 1 | 1984 | 1 | 0.010 |
Why?
|
| Hexamethonium Compounds | 1 | 1984 | 6 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 46 | 0.010 |
Why?
|
| Atropine | 1 | 1984 | 53 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 161 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 25 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1984 | 81 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 38 | 0.010 |
Why?
|
| Indomethacin | 1 | 2003 | 58 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 691 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 2, Group C, Member 1 | 1 | 2003 | 1 | 0.010 |
Why?
|
| Peroxisome Proliferators | 1 | 2003 | 2 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1983 | 36 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 84 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 293 | 0.010 |
Why?
|
| Naltrexone | 1 | 1984 | 139 | 0.010 |
Why?
|
| Tocopherols | 1 | 2002 | 6 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2002 | 38 | 0.010 |
Why?
|
| Tretinoin | 1 | 2003 | 128 | 0.010 |
Why?
|
| Methoxamine | 1 | 1982 | 2 | 0.010 |
Why?
|
| Phentolamine | 1 | 1982 | 8 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2002 | 47 | 0.010 |
Why?
|
| Prazosin | 1 | 1982 | 8 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2005 | 217 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1982 | 33 | 0.010 |
Why?
|
| COS Cells | 1 | 2002 | 163 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 148 | 0.010 |
Why?
|
| Propranolol | 1 | 1982 | 43 | 0.010 |
Why?
|
| Epinephrine | 1 | 1982 | 92 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 290 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 423 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 476 | 0.010 |
Why?
|
| Computational Biology | 1 | 2004 | 578 | 0.010 |
Why?
|
| Bacterial Translocation | 1 | 2000 | 26 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 433 | 0.010 |
Why?
|
| Exotoxins | 1 | 2000 | 21 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2003 | 384 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2006 | 782 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 740 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1999 | 10 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1999 | 81 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1999 | 49 | 0.010 |
Why?
|
| Blood | 1 | 1999 | 68 | 0.010 |
Why?
|
| LLC-PK1 Cells | 1 | 1996 | 2 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1996 | 138 | 0.010 |
Why?
|
| Clone Cells | 1 | 1996 | 219 | 0.010 |
Why?
|
| RNA Probes | 1 | 1995 | 16 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 79 | 0.010 |
Why?
|
| Alkalosis | 1 | 1995 | 10 | 0.010 |
Why?
|
| Rodentia | 1 | 1994 | 47 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1994 | 58 | 0.010 |
Why?
|
| Glutathione | 1 | 1993 | 105 | 0.010 |
Why?
|
| Thy-1 Antigens | 1 | 1992 | 16 | 0.010 |
Why?
|
| CD5 Antigens | 1 | 1992 | 13 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1992 | 37 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 1992 | 82 | 0.010 |
Why?
|
| Lymphokines | 1 | 1992 | 75 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1992 | 97 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1992 | 96 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1992 | 113 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 111 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1992 | 424 | 0.000 |
Why?
|
| Calcium Radioisotopes | 1 | 1988 | 4 | 0.000 |
Why?
|
| Methylglucosides | 1 | 1987 | 1 | 0.000 |
Why?
|
| 3-O-Methylglucose | 1 | 1987 | 2 | 0.000 |
Why?
|
| Phlorhizin | 1 | 1987 | 3 | 0.000 |
Why?
|
| Sympathectomy, Chemical | 1 | 1987 | 6 | 0.000 |
Why?
|
| Hydroxydopamines | 1 | 1987 | 7 | 0.000 |
Why?
|
| Oxidopamine | 1 | 1987 | 9 | 0.000 |
Why?
|
| Sulfates | 1 | 1987 | 38 | 0.000 |
Why?
|
| Alanine | 1 | 1987 | 83 | 0.000 |
Why?
|
| Ion Exchange | 1 | 1985 | 6 | 0.000 |
Why?
|
| Tyramine | 1 | 1985 | 3 | 0.000 |
Why?
|
| Enkephalin, Methionine | 1 | 1985 | 5 | 0.000 |
Why?
|
| Kinins | 1 | 1985 | 31 | 0.000 |
Why?
|
| Receptors, Opioid | 1 | 1985 | 23 | 0.000 |
Why?
|